MINNEAPOLIS, May 23, 2011 /PRNewswire/ -- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, announced today the Canadian Intellectual Property Office has issued patent Number 2,495,747 for the Company’s Streamway System “for disposing of liquid surgical waste for protection of healthcare workers.” The patent was granted to the Company in April of 2011.
Chad Ruwe, Chief Operating Officer of BioDrain Medical Inc., said, “We are extremely pleased to have been granted the Canadian patent for our Streamway System. We now have patent protection in Europe, the United States and Canada with additional patents pending.”
Mr. Ruwe continued, “As we place our Streamway System in hospitals and ambulatory surgical centers, we are receiving an enthusiastic response from medical personnel who use it daily. They report many notable advantages, most importantly that the potential for staff exposure to patient body fluids has been significantly reduced, the system is easy to use and is fully automated, providing the needed suction control and real-time fluid measurement needed for their patients. In addition, supplies have been greatly reduced, storage space has been freed up, and hazardous waste costs have been lowered. We are confident the Streamway System is setting a new standard of safety and efficiency for disposal of liquid surgical waste.”
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid management system that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and the related germs, viruses and diseases that are potentially found in the surgical environment. Today’s manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain’s Streamway system fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).
BioDrain’s Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected, canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain’s Streamway system, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country.
Forward-looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company’s ability to implement its long range business plan for various applications of its technology; the company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company’s reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company’s financial position. See the Company’s most recent Quarterly Report on Form 10-Q and related 8-K filings.
Investor Relations Contact:
Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: info@cfsg1.com
SOURCE BioDrain Medical, Inc.
